Putting a value on how much an early-stage biotech company is worth is no easy task. Raising money for an early-stage biotech is even harder. But the good news is that last year was a record year for … more →
BIO on the roadecreese wrote 1 year ago: Putting a value on how much an early-stage biotech company is worth is no easy task. Raising money f … more →
ecreese wrote 1 year ago: Attendees awoke to the news this morning about GlaxoSmithKline’s announcement that it will pay mill … more →
ecreese wrote 1 year ago: More than 60 company presentations are scheduled to take place between today and tomorrow. Whether y … more →
ecreese wrote 1 year ago: While the economy may not be as robust as it has in recent years, there certainly was no sign of tha … more →
ecreese wrote 1 year ago: The marathon may be over, but that doesn’t mean there isn’t plenty more activity going o … more →